Will Junker, head of manufacturing quality at Kite Pharma, talks to Cell & Gene: The Podcast listeners about the challenges associated with capacity planning, partnering with CDMOs, and prioritizing inventory over time-to-market. Learn why a better understanding of the vector manufacturing process is critical to bringing continuous and secure supply to market. Listen now and subscribe so you never miss an episode!
By George Vratsanos, M.D., and Luke Devey, M.D., Ph.D., Janssen Immunology
Last year, Janssen Biotech and the University of Oxford established a collaboration to understand pathogenic pathways driving immune-mediated inflammatory diseases. They have been creating a cellular map of expressed genes and proteins. This article shares what the collaboration has accomplished so far.
Explore the challenges impacting clinical supply chains, the solutions to overcome these complexities, and understand why it is crucial to pick the right supply chain provider for vaccine storage and distribution.
Executives share behind-the-scenes updates on their efforts to develop a COVID-19 vaccine, where the companies have all adopted a collaborative mindset to arrive at a vaccine as quickly and safely as possible.
One hundred thirty-four outsourcers of biologic drug substance provided insight into how their pipelines are impacting outsourcing practices. Two-thirds (63%) said a focus on new, innovative treatments will impact outsourcing decisions.
The industry is now considering non-animal methods for toxicology studies. The move is toward more predictive models such as machine learning and organ-on-a-chip to drive safer and more efficient science.